Ladenburg Thalmann has recently reduced BioNano Genomics Inc (BNGO) stock to Neutral rating, as announced on November 15, 2024, according to Finviz. Earlier, on September 10, 2024, BTIG Research had ...

SAN DIEGO - Bionano Genomics , Inc. (NASDAQ:BNGO), currently valued at $20.9 million in market capitalization, announced ...

On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.21 which represents a decrease of $-0.01 or -4.55% from the prior close of $0.22. The stock opened at $0.22 and ...

Revenues for the fourth quarter 2024 are expected to be in the range of $7.9 million to $8.1 million, an estimated decrease ...

BNGO) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 39,682,540 shares of its ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks ...

EST Bionano Genomics (BNGO) files to sell 50.56M share of common stock for holdersDon't Miss Our New Year's Offers:Discover the latest ...

including but not limited to automotive, advertising networks, apparel & accessories, convenience stores, food service/QSR, gaming, theater, and stadium venues. Contacts Media Inquiries Breanne Ngo ...

Bionano Genomics, Inc. has announced a definitive agreement with institutional investors to sell approximately 39.7 million shares of common stock and warrants to purchase an equal number of ...

Inc. (Nasdaq: BNGO) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate of 39,682,540 shares of its common ...

Bionano Genomics (BNGO) stock rallied 19% Friday afternoon after the company announced a $10M registered direct offering priced at-the-market under Nasdaq rules. Read more here.